tirzepatide vs semaglutide differences efficacy safety Comparative and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide vs Semaglutide Compared |
Description
Vomiting rates were 6-10% for tirzepatide and 8% for semaglutide
The evidence for this approach is limited but growing
However, tirzepatides psychiatric safety data is based on smaller sample sizes and shorter follow-up periods, leaving room for further research
10 Women tend to lose more weight than men when using GLP-1 medications
At 10 mg/mL, 5 mg equals 50 units
Patients should be monitored every 48 weeks during the titration phase and every 36 months once the treatment stabilizes
